Iridex (IRIX) Net Income towards Common Stockholders Growth (3y) (2014 - 2026)
Iridex (IRIX) Net Income towards Common Stockholders Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 51.47% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -7.83% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 11.15% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1,825.47% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 17.54% |
| 10 | Iridex | 13.27 Mn | 8.59 Mn | 4.30 Mn | 22.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 36.94% |
| Jan 3, 2026 | -26.59% |
| Sep 27, 2025 | 3.80% |
| Jun 28, 2025 | 23.74% |
| Mar 29, 2025 | 10.99% |
| Dec 28, 2024 | -42.58% |
| Sep 28, 2024 | 3.71% |
| Jun 29, 2024 | -57.72% |
| Mar 30, 2024 | -19.89% |
| Sep 30, 2023 | -0.67% |
| Jul 1, 2023 | 0.17% |
| Apr 1, 2023 | -8.18% |
| Dec 31, 2022 | 82.69% |
| Oct 1, 2022 | 0.34% |
| Jul 2, 2022 | 2.52% |
| Apr 2, 2022 | 7.77% |
| Jan 1, 2022 | -54.49% |
| Oct 2, 2021 | 11.03% |
| Jul 3, 2021 | 34.34% |
| Apr 3, 2021 | 17.68% |